Approvals (Drugs@FDA)

LANREOTIDE ACETATE

AMNEAL · LANREOTIDE ACETATE

ANDA218217Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218217
Sponsor name
AMNEAL
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260918
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    LANREOTIDE ACETATE
    Reference standard
    No
    Dosage form
    SOLUTION
    Route
    SUBCUTANEOUS
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      LANREOTIDE ACETATE
      Strength
      EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
Harmonized identifiers (openFDA)
Application number
ANDA218217
Brand name
LANREOTIDE ACETATE
Generic name
LANREOTIDE ACETATE
Manufacturer name
Amneal Pharmaceuticals LLC
Product NDC
70121-2517
Product type
HUMAN PRESCRIPTION DRUG
Route
SUBCUTANEOUS
Substance name
LANREOTIDE ACETATE
RxCUI
749814
SPL ID
43b3c820-dda0-4514-92cd-3ad85019d105
SPL set ID
e240b3b9-7a07-46b5-bacc-04e915d4ebd4
Package NDC
70121-2517-5
UNII
IEU56G3J9C
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.